DR dose-dependently decreased the levels of PHF-tau in the cortex, and a decreasing trend in PHF-tau was observed in the hippocampus after DR treatment ( Figure 2C ).
← all excerpts
A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer's Disease and Its Target Molecule.
1
—
—